Aqur Biosciences, Inc.
New Filing
CIK: 0002094075·Pharmaceuticals·NEVADA·Filed: Sep 18, 2026
Total Offering
$1,500,000
Amount Sold
$1,500,000
Investors
7
First Sale
Sep 3, 2026
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Michael A Fole | |
| Jeffrey B Wolin | |
| James Hess Leach | |
| Michel F Denarie | |
| Tomi K Sawyer |
Company
SEC Filing
0001640334-26-001574
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free